A Preliminary Study Introducing Electronic Patient-Reported Outcome (ePRO) Using Bring Your Own Device (BYOD) in Post-marketing Surveillance in Japan
Our two-week pilot indicates that ePRO can achieve data completeness comparable to paper in motivated clinics. The points to consider when using ePRO in actual PMS were confirmed. Further assessment in actual studies conducted in compliance with local regulations is needed.
Authors
- Nobushige Matsuoka
- Tetsuya Hiraiwa (ORCID: https://orcid.org/0000-0003-3221-345X)
- Akira Hoshino
- Hidetoshi Misawa
- Natsuno Yamashita
- Yoko Sato (ORCID: https://orcid.org/0000-0002-9073-044X)
- Hiromi Yamaguchi
- N. Sugimoto
- M. Kawai
- Mika Morimasa
Institutions
- Pfizer (Japan) (JP)
Publication Details
- Journal
- Therapeutic Innovation & Regulatory Science
- Published
- 2025-09-24
- DOI
- https://doi.org/10.1007/s43441-025-00873-0
- Primary Topic
- Digital Mental Health Interventions
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Pfizer